Subbu Nambi
Stock Analyst at Guggenheim
(1.56)
# 3,039
Out of 4,818 analysts
35
Total ratings
23.08%
Success rate
-9.49%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Reiterates: Buy | $10 | $5.82 | +71.82% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $45.13 | +32.95% | 2 | Apr 11, 2025 | |
| NEOG Neogen | Maintains: Buy | $15 → $13 | $5.03 | +158.45% | 2 | Apr 10, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $7.58 | - | 2 | Apr 9, 2025 | |
| VCYT Veracyte | Maintains: Buy | $45 → $37 | $32.10 | +15.26% | 3 | Apr 9, 2025 | |
| TEM Tempus AI | Reiterates: Buy | n/a | $49.89 | - | 2 | Feb 25, 2025 | |
| BRKR Bruker | Reiterates: Buy | n/a | $38.66 | - | 3 | Feb 24, 2025 | |
| GH Guardant Health | Reiterates: Buy | $56 | $46.77 | +19.75% | 5 | Feb 24, 2025 | |
| ILMN Illumina | Maintains: Buy | $170 → $150 | $76.13 | +97.03% | 2 | Feb 7, 2025 | |
| NTRA Natera | Maintains: Buy | $170 → $200 | $149.79 | +33.52% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $34.24 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.14 | +91.08% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.75 | +699.79% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.01 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $148.75 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $53 | $38.65 | +37.13% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.28 | +12.23% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.17 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.25 | - | 1 | Dec 14, 2023 |
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $5.82
Upside: +71.82%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $45.13
Upside: +32.95%
Neogen
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $5.03
Upside: +158.45%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.58
Upside: -
Veracyte
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $32.10
Upside: +15.26%
Tempus AI
Feb 25, 2025
Reiterates: Buy
Price Target: n/a
Current: $49.89
Upside: -
Bruker
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $38.66
Upside: -
Guardant Health
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $46.77
Upside: +19.75%
Illumina
Feb 7, 2025
Maintains: Buy
Price Target: $170 → $150
Current: $76.13
Upside: +97.03%
Natera
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $149.79
Upside: +33.52%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $34.24
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.14
Upside: +91.08%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.75
Upside: +699.79%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.01
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $148.75
Upside: -
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $38.65
Upside: +37.13%
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $22.28
Upside: +12.23%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.25
Upside: -